Protective and immunomodulatory effect of Gingyo-san in a murine model of acute lung inflammation

Journal of Ethnopharmacology

Volumn 111, Issue 2, 2007, Pages 418-426

  Yeh, Chia Chou ^a,b   Lin, Chih Che ^a   Wang, Shulhn Der ^a   Hung, Che Ming ^d   Yeh, Ming Hsien ^b   Liu, Ching Ju ^b   Kao, Shung Te ^a,c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d FISHERIES RESEARCH INSTITUTE   (Taiwan)

Author keywords

AP 1; Gingyo san; Inflammatory cytokine; Lipopolysaccharide; NF B

Indexed keywords

GINGYO SAN EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; PLANT EXTRACT; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGYO SAN; IMMUNOMODULATION; IN VIVO STUDY; LUNG EDEMA; LUNG PARENCHYMA; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NITROSATIVE STRESS; NONHUMAN; PLANT; PNEUMONIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACUTE DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; FEMALE; LUNG; MICE; MICE, INBRED BALB C; PLANT EXTRACTS; PNEUMONIA;

MURINAE; MUS;

EID: 34047118740     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2006.12.014     Document Type: Article

References (46)

1. Adcock I.M. Transcription factors as activators of gene transcription: AP-1 and NF-kappa B. Monaldi Archives for Chest Disease 52 (1997) 178-186
2. Agouridakis P., Kyriakou D., Alexandrakis M.G., Prekates A., Perisinakis K., Karkavitsas N., and Bouros D. The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome. Respiratory Research 3 (2002) 25
3. Bachofen M., and Weibel E.R. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clinical Chest Medicine 3 (1982) 35-56
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 (1976) 248-254
5. Chen C.C., Chow M.P., Huang W.C., Lin Y.C., and Chang Y.J. Flavonoids inhibit tumor necrosis factor-alpha-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-kappaB: structure-activity relationships. Molecular Pharmacology 66 (2004) 683-693
6. Chen Q.M., Huang L.J., and Wang W. Clinical application and pharmacological experiment study of yingqiao powder. Hunan Guiding Journal of Traditional Chinese Medicine 9 (2003) 36-39
7. Chignard M., and Balloy V. Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide. American Journal of Physiology-Lung Cellular and Molecular Physiology 279 (2000) L1083-L1090
8. Davidson K.G., Bersten A.D., Barr H.A., Dowling K.D., Nicholas T.E., and Doyle I.R. Lung function, permeability, and surfactant composition in oleic acid-induced acute lung injury in rats. American Journal of Physiology-Lung Cellular and Molecular Physiology 279 (2000) L1091-L1102
9. Donnelly S.C., Strieter R.M., Reid P.T., Kunkel S.L., Burdick M.D., Armstrong I., Mackenzie A., and Haslett C. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Annals of Internal Medicine 125 (1996) 191-196
10. Dreyfuss D., and Ricard J.D. Acute lung injury and bacterial infection. Clinics in Chest Medicine 26 (2005) 105-112
11. Gerard C., Frossard J.L., Bhatia M., Saluja A., Gerard N.P., Lu B., and Steer M. Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. Journal of Clinical Investigation 100 (1997) 2022-2027
12. Giri S.N., Hyde D.M., and Hollinger M.A. Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. Thorax 48 (1993) 959-966
13. Goodman R.B., Pugin J., Lee J.S., and Matthay M.A. Cytokine-mediated inflammation in acute lung injury. Cytokine and Growth Factor Reviews 14 (2003) 523-535
14. Haddad I.Y., Pataki G., Hu P., Galliani C., Beckman J.S., and Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. Journal of Clinical Investigation 94 (1994) 2407-2413
15. Hanada T., and Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine and Growth Factor Reviews 13 (2002) 413-421
16. Harrod K.S., Mounday A.D., and Whitsett J.A. Adenoviral E3-14.7K protein in LPS-induced lung inflammation. American Journal of Physiology-Lung Cellular and Molecular Physiology 278 (2000) L631-L639
17. Heflin A.C., and Brigham K.L. Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. Journal of Clinical Investigation 68 (1981) 1253-1260
18. Jansson A.H., Eriksson C., and Wang X. Lung inflammatory responses and hyperinflation induced by an intratracheal exposure to lipopolysaccharide in rats. Lung 182 (2004) 163-171
19. Kobayashi M., Davis S.M., Utsunomiya T., Pollard R.B., and Suzuki F. Antiviral effect of gingyo-san, a traditional Chinese herbal medicine, on influenza A2 virus infection in mice. American Journal of Chinese Medicine 27 (1999) 53-62
20. Kollef M.H., and Schuster D.P. The acute respiratory distress syndrome. New England Journal of Medicine 332 (1995) 27-37
21. Kristof A.S., Marks-Konczalik J., and Moss J. Mitogen-activated protein kinases mediate activator protein-1-dependent human inducible nitric-oxide synthase promoter activation. Journal of Biology Chemistry 276 (2001) 8445-8452
22. Kurdowska A., Noble J.M., Steinberg K.P., Ruzinski J.T., Hudson L.D., and Martin T.R. Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity. American Journal Respiratory and Critical Care Medicine 163 (2001) 463-468
23. Kurokawa M., Yamamura J., Li Z., Sato H., Hitomi N., Tatsumi Y., and Shiraki K. Antipyretic activity of gingyo-san, a traditional medicine, in influenza virus-infected mice. Chemical and Pharmaceutical Bulletin 46 (1998) 1444-1447
24. Li Q., and Verma I.M. NF-κB regulation in the immune system. Nature Reviews Immunology 2 (2002) 725-734
25. Liaudet L., Soriano F.G., and Szabo C. Biology of nitric oxide signaling. Critical Care Medicine 28 (2000) N37-N52
26. Lynch E.L., Little F.F., Wilson K.C., Center D.M., and Cruikshank W.W. Immunomodulatory cytokines in asthmatic inflammation. Cytokine and Growth Factor Reviews 14 (2003) 489-502
27. Majano P., Alonso-Lebrero J.L., Janczyk A., Martin-Vichez S., Molina-Jimenez F., Brieva A., Pivel J.P., Gonzalez S., Lopez-Cabrera M., and Moreno-Otero R. AM3 inhibits LPS-induced iNOS expression in mice. International Immunopharmacology 5 (2005) 1165-1170
28. Matthay M.A., Geiser T., Matalon S., and Ischiropoulos H. Oxidant-mediated lung injury in the acute respiratory distress syndrome. Critical Care Medicine 27 (1999) 2028-2030
29. Martin T.R. Recognition of bacterial endotoxin in the lungs. American Journal of Respiratory Cell and Molecular Biology 23 (2000) 128-132
30. Martin T.R., Mathison J.C., Tobias P., Leturcq D.J., Moriarty A.M., and Ulevitch R.J. Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs. Journal of Clinical Investigation 90 (1992) 2209-2219
31. Meduri G.U. Clinical review: a paradigm shift: the bidirectional effect of inflammation on bacterial growth. Clinical implications for patients with acute respiratory distress syndrome. Critical Care 6 (2002) 24-29
32. Palanki M.S. Inhibitors of AP-1 and NF-kappa B mediated transcriptional activation: therapeutic potential in autoimmune diseases and structural diversity. Current Medicinal Chemistry 9 (2002) 219-227
33. Pittet J.F., Griffiths M.J.D., Geiser T., Kaminski N., Dalton S.L., and Huang X.Z. TGF-b1 is a critical mediator of acute lung injury. Journal of Clinical Investigation 107 (2001) 1537-1544
34. Puneet P., Moochhala S., and Bhatia M. Chemokines in acute respiratory distress syndrome. American Journal of Physiology-Lung Cellular and Molecular Physiology 288 (2005) L3-L15
35. Sadikot R.T., Han W., Everhart M.B., Zoia O., Peebles R.S., Jansen E.D., Yull F.E., Christman J.W., and Blackwell T.S. Selective IκB kinase expression in airway epithelium generates neutrophilic lung inflammation. Journal of Immunology 170 (2003) 1091-1098
36. Sato K., Kadiiska M.B., Ghio A.J., Corbett J., Fann Y.C., Holland S.M., Thurman R.G., and Mason R.P. In vivo lipid-derived free radical formation by NADPH oxidase in acute lung injury induced by lipopolysaccharide: a model for ARDS. FASEB Journal 16 (2002) 1713-1720
37. Shi Y., Shi R.B., Liu B., and Lu Y.R. Studies on antiviral flavonoids in yinqiaosan powder. China Journal of Chinese Materia Medica 26 (2001) 320-323
38. Shinbori T., Walczak H., and Krammer P.H. Activated T killer cells induce apoptosis in lung epithelial cells and the release of pro-inflammatory cytokine TNF-alpha. European Journal of Immunology 34 (2004) 1762-1770
39. Strieter R.M., Kunkel S.L., Keane M.P., and Standiford T.J. Chemokines in lung injury: Thomas A. Neff Lecture. Chest 116 (1999) 103S-110S
40. Takala A., Jousela I., Takkunen O., Kautiainen H., Jansson S.E., Orpana A., Karonen S.L., and Repo H. A prospective study of inflammation markers in patients at risk of indirect acute lung injury. Shock 17 (2002) 252-257
41. Tsai W.C., Strieter R.M., Wilkowski J.M., Bucknell K.A., Burdick M.D., Lira S.A., and Standiford T.J. Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. Journal of Immunology 161 (1988) 2435-2440
42. Varley A.W., Coulthard M.G., Meidell R.S., Gerard R.D., and Munford R.S. Inflammation-induced recombinant protein expression in vivo using promoters from acute-phase protein genes. Proceedings of the National Academy of Sciences of United States of America 92 (1995) 5346-5350
43. Wright R.M., Ginger L.A., Kosila N., Elkins N.D., Essary B., McManaman J.L., and Repine J.E. Mononuclear phagocyte xanthine oxidoreductase contributes to cytokine-induced acute lung injury. American Journal of Respiratory Cell and Molecular Biology 30 (2004) 479-490
44. Xiao J.R., Wu H.J., Guo Y., Huang H.M., Qiu S.H., and Guo G.H. A comparative study on the pharmacodynamic effects of different preparations of yinqiao powder on bacteria and viruses. Journal of Traditional Chinese Medicine University of Hunan 23 (2003) 15-18
45. Xiong H., Zhu C., Li F., Hegazi R., He K., Babyatsky M., Bauer A.J., and Plevy S.E. Inhibition of interleukin-12 p40 transcription and NF-kappaB activation by nitric oxide in murine macrophages and dendritic cells. Journal of Biology Chemistry 279 (2004) 10776-10783
46. Yeh C.C., Lin C.C., Wang S.D., Chen Y.S., Su B.H., and Kao S.T. Protective and anti-inflammatory effect of a traditional Chinese medicine, Xia-Bai-San, by modulating lung local cytokine in a murine model of acute lung injury. International Immunopharmacology 6 (2006) 1506-1514